An observational study in Epilepsy, sponsored by Assiut University. Not yet recruiting. Open to participants aged 1 Year to 18 Years. Per ClinicalTrials.gov, last updated 2026-10-20.
Sponsored by Assiut University · Observational
This prospective study aims to assess changes in complete blood count parameters among Egyptian children with epilepsy receiving antiseizure medications.
Antiseizure medications are the mainstay of treatment for children with epilepsy. Some of these medications may affect hematological parameters including hemoglobin, white blood cell count, and platelet count.
This observational study will evaluate complete blood count parameters in newly diagnosed children with epilepsy before starting antiseizure medication and at follow-up time points after treatment initiation.
1,842 studies on the registry are indexed under Epilepsy; 423 are open to participants now.
This study's planned enrollment of 80 is below the median of 101 across 536 observational studies indexed under Epilepsy.
Browse Epilepsy studies →Assiut University is the lead sponsor of 5,050 studies on the registry; 2,174 are open to participants now.
Of its 14 completed or terminated interventional studies of FDA-regulated products, 0 (0%) have results posted.
Counted across the registry records on this site, refreshed daily.
Egyptian children aged 1 to 18 years newly diagnosed with epilepsy who have not previously received antiseizure medications, followed at Assiut University Children's Hospital.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Newly diagnosed children with epilepsy who will receive antiseizure medications and undergo serial complete blood count assessments.
Change in platelet count
Mean change in platelet count from baseline after initiation of antiseizure medication.
Time frame: At 3 months
Change in hemoglobin level
Mean change in hemoglobin level from baseline after initiation of antiseizure medication.
Time frame: At 3 months
Change in white blood cell count
Mean change in white blood cell count from baseline after initiation of antiseizure medication.
Time frame: At 3 months
Change in absolute neutrophil count
Mean change in absolute neutrophil count from baseline after initiation of antiseizure medication.
Time frame: At 3 months
Mean Platelet Count at 6 Months
Mean platelet count at 6 months after initiation of antiseizure medication..
Time frame: At 6 months
No study locations are listed for this record.
Plan to share: No
No publications or documents are linked to this record.
From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗
This study is not yet recruiting, as verified in Oct 2026. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.